225 related articles for article (PubMed ID: 32408241)
1. Insurance status and level of education predict disparities in receipt of treatment and survival for anal squamous cell carcinoma.
Patel KS; Alhatem A; Gadde U; Ahlawat S; Lambert C; Schwartz RA; Dalla Piazza M
Cancer Epidemiol; 2020 Aug; 67():101723. PubMed ID: 32408241
[TBL] [Abstract][Full Text] [Related]
2. Association of Insurance and Community-Level Socioeconomic Status With Treatment and Outcome of Squamous Cell Carcinoma of the Pharynx.
Shin JY; Yoon JK; Shin AK; Blumenfeld P; Mai M; Diaz AZ
JAMA Otolaryngol Head Neck Surg; 2017 Sep; 143(9):899-907. PubMed ID: 28662244
[TBL] [Abstract][Full Text] [Related]
3. Socioeconomic disparities in timeliness of care and outcomes for anal cancer patients.
Ahmad TR; Susko M; Lindquist K; Anwar M
Cancer Med; 2019 Dec; 8(17):7186-7196. PubMed ID: 31595720
[TBL] [Abstract][Full Text] [Related]
4. Racial disparities in receipt of standard chemoradiation in anal squamous cell carcinoma, an analysis of the National Cancer Database.
Bian SX; Chen DH; Lin E
Cancer Med; 2021 Jan; 10(2):575-585. PubMed ID: 33305908
[TBL] [Abstract][Full Text] [Related]
5. Is There an Association Between Insurance Status and Survival and Treatment of Primary Bone and Extremity Soft-tissue Sarcomas? A SEER Database Study.
Smartt AA; Jang ES; Tyler WK
Clin Orthop Relat Res; 2020 Mar; 478(3):527-536. PubMed ID: 31390340
[TBL] [Abstract][Full Text] [Related]
6. Socioeconomic Factors Affect Presentation Stage and Survival in Sinonasal Squamous Cell Carcinoma.
Jafari A; Shen SA; Qualliotine JR; Lehmann AE; Humphreys IM; Abuzeid WM; Bergmark RW; Gray ST
Laryngoscope; 2021 Nov; 131(11):2421-2428. PubMed ID: 33844294
[TBL] [Abstract][Full Text] [Related]
7. Association between insurance status at diagnosis and overall survival in chronic myeloid leukemia: A population-based study.
Perry AM; Brunner AM; Zou T; McGregor KL; Amrein PC; Hobbs GS; Ballen KK; Neuberg DS; Fathi AT
Cancer; 2017 Jul; 123(13):2561-2569. PubMed ID: 28464280
[TBL] [Abstract][Full Text] [Related]
8. Impact of socioeconomic status on survival for patients with anal cancer.
Lin D; Gold HT; Schreiber D; Leichman LP; Sherman SE; Becker DJ
Cancer; 2018 Apr; 124(8):1791-1797. PubMed ID: 29527660
[TBL] [Abstract][Full Text] [Related]
9. Insurance status and disparities in disease presentation, treatment, and outcomes for men with germ cell tumors.
Markt SC; Lago-Hernandez CA; Miller RE; Mahal BA; Bernard B; Albiges L; Frazier LA; Beard CJ; Wright AA; Sweeney CJ
Cancer; 2016 Oct; 122(20):3127-3135. PubMed ID: 27500561
[TBL] [Abstract][Full Text] [Related]
10. A Population-Based Cohort Analysis of Chemoradiation Versus Radiation Alone for Definitive Treatment of Stage I Anal Cancer in Older Patients.
Buckstein M; Arens Y; Wisnivesky J; Gaisa M; Goldstone S; Sigel K
Dis Colon Rectum; 2018 Jul; 61(7):787-794. PubMed ID: 29771796
[TBL] [Abstract][Full Text] [Related]
11. Relationship between Insurance Type at Diagnosis and Hepatocellular Carcinoma Survival.
Adler Jaffe S; Myers O; Meisner ALW; Wiggins CL; Hill DA; McDougall JA
Cancer Epidemiol Biomarkers Prev; 2020 Feb; 29(2):300-307. PubMed ID: 31796525
[TBL] [Abstract][Full Text] [Related]
12. Anal cancer survival: a socioeconomic analysis.
Ali F; Ghareeb AE; Jha A; Van der Voet H; Garg D; Jha M
Ann R Coll Surg Engl; 2021 Mar; 103(3):191-196. PubMed ID: 33645271
[TBL] [Abstract][Full Text] [Related]
13. The effect of guideline-concordant care in mitigating insurance status disparities in cervical cancer.
Wu J; Huang Y; Tergas AI; Melamed A; Khoury-Collado F; Hou JY; St Clair CM; Ananth CV; Hershman DL; Wright JD
Gynecol Oncol; 2020 Nov; 159(2):309-316. PubMed ID: 32800656
[TBL] [Abstract][Full Text] [Related]
14. Chemoradiation versus local excision in treatment of stage I anal squamous cell carcinoma: A population-based analysis.
Gao X; Goffredo P; Kahl AR; Charlton ME; Weigel RJ; Hassan I
Eur J Surg Oncol; 2020 Sep; 46(9):1663-1667. PubMed ID: 32199768
[TBL] [Abstract][Full Text] [Related]
15. The effect of health insurance on childhood cancer survival in the United States.
Lee JM; Wang X; Ojha RP; Johnson KJ
Cancer; 2017 Dec; 123(24):4878-4885. PubMed ID: 28891067
[TBL] [Abstract][Full Text] [Related]
16. Medicaid and Uninsured Hepatocellular Carcinoma Patients Have More Advanced Tumor Stage and Are Less Likely to Receive Treatment.
Wang J; Ha J; Lopez A; Bhuket T; Liu B; Wong RJ
J Clin Gastroenterol; 2018; 52(5):437-443. PubMed ID: 28723861
[TBL] [Abstract][Full Text] [Related]
17. Education and insurance status: Impact on treatment and survival of sinonasal cancer patients.
Agarwal P; Jones EA; Devaiah AK
Laryngoscope; 2020 Mar; 130(3):649-658. PubMed ID: 31165512
[TBL] [Abstract][Full Text] [Related]
18. Does race impact survival for patients with anal squamous cell carcinoma?
Fields AC; Welten VM; Lu P; Goldberg JE; Irani J; Bleday R; Melnitchouk N
J Surg Oncol; 2019 Dec; 120(7):1201-1207. PubMed ID: 31549446
[TBL] [Abstract][Full Text] [Related]
19. Pre-treatment magnetic resonance-based texture features as potential imaging biomarkers for predicting event free survival in anal cancer treated by chemoradiotherapy.
Hocquelet A; Auriac T; Perier C; Dromain C; Meyer M; Pinaquy JB; Denys A; Trillaud H; Denis De Senneville B; Vendrely V
Eur Radiol; 2018 Jul; 28(7):2801-2811. PubMed ID: 29404766
[TBL] [Abstract][Full Text] [Related]
20. Comparative Survival of Patients With Anal Adenocarcinoma, Squamous Cell Carcinoma of the Anus, and Rectal Adenocarcinoma.
Franklin RA; Giri S; Valasareddy P; Lands LT; Martin MG
Clin Colorectal Cancer; 2016 Mar; 15(1):47-53. PubMed ID: 26362848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
